Open AccessContrast Sensitivity Changes in Center Involving Diabetic Macular Edema Treated with Aflibercept
Author(s) -
Donald R Nixon,
Nicholas Flinn,
Claudia Enderlein
Publication year - 2021
Publication title -
clinical ophthalmology
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 1.025
H-Index - 56
eISSN - 1177-5483
pISSN - 1177-5467
DOI - 10.2147/opth.s338478
Subject(s) - medicine , aflibercept , ophthalmology , visual acuity , diabetic macular edema , macular edema , diabetic retinopathy , retinal , diabetes mellitus , surgery , bevacizumab , chemotherapy , endocrinology
To characterize the changes in contrast sensitivity (CS) and retinal anatomy in patients with center involving diabetic macular edema (CDME) measured from baseline to post-loading doses of aflibercept.